Kleiner Perkins has been investing in technology for more than fifty years. This week, it raised $3.5 billion with a singular focus: artificial intelligence. According to Bloomberg, the firm structured the raise as two separate vehicles, $1 billion for KP22, its 22nd early-stage fund, and $2.5 billion for a growth-stage fund. Both are dedicated to AI.
That total is up from approximately $2 billion raised for KP’s previous flagship fund in 2024, according to Bloomberg. The 75% increase in fund size in a single cycle is the number to hold onto.
Why it matters
When a firm with Kleiner Perkins’ history, early backer of Genentech, Google, Amazon, and Stripe, scales its AI commitment by 75% in a single fund cycle, it isn’t chasing a trend. It’s making a structural call. The dual-fund structure is deliberate. Early-stage capital ($1 billion, KP22) gives the firm entry into companies that will take years to mature. Growth-stage capital ($2.5 billion) lets it write larger checks into companies that have already demonstrated product-market fit and are ready to scale.
Kleiner Perkins characterized the current environment as an “AI super-cycle.” That’s the firm’s framing, not an independent market assessment. But the capital allocation behind that framing is concrete. KP’s assets under management now exceed $21 billion, according to Techsnif.
Context
This close lands in the same week that OpenAI announced a $110 billion funding round. The two events aren’t directly related, but they’re thematically connected. The largest check in the history of private funding went to a frontier AI lab. One of the most established venture firms in the world simultaneously scaled its AI fund by 75%. Together, they describe a capital market that has made a directional decision: AI is where institutional money is going, at every level of the stack.
The early-stage allocation matters specifically for founders. A $1 billion early-stage fund from Kleiner Perkins means the firm can lead or co-lead seed and Series A rounds for companies that don’t yet have revenue. The growth-stage fund means it can follow its winners up the capital ladder without competing with later-stage-only funds for allocation.
What to watch
Watch the portfolio. The deals KP closes out of KP22 over the next 12 to 18 months will be a leading indicator of where the firm’s AI thesis is pointing, which verticals, which technical approaches, which founding team profiles. That’s institutional signal that’s harder to get from a fund announcement alone.
Also watch fund sizing at peer firms. If Andreessen Horowitz, Sequoia, and Accel follow with similarly scaled AI vehicles in 2026, the pattern becomes a sector-wide commitment. If KP’s raise remains an outlier, the thesis is more firm-specific.
TJS synthesis
The “AI super-cycle” phrase will get quoted widely. The more useful signal is the structure of the bet: 29% early-stage, 71% growth. That allocation says KP believes the application layer has a clear growth opportunity right now, but it isn’t writing off early-stage optionality. It’s covering the full capital stack. For founders seeking AI funding in 2026, this is a firm that’s actively deploying across stage. For enterprise buyers watching vendor consolidation, the growth-stage fund is the vehicle to watch, that’s where the next generation of scaled AI companies will get their institutional backing.